Literature DB >> 15111546

The case for intravenous arginine stimulation in lieu of mixed-meal tolerance tests as outcome measure for intervention studies in recent-onset type 1 diabetes.

Carla Greenbaum1, Kristy Seidel, Catherine Pihoker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15111546     DOI： 10.2337/diacare.27.5.1202

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  6 in total

1.  Capturing residual beta cell function in type 1 diabetes.

Authors:  Flemming Pociot
Journal:  Diabetologia       Date:  2018-11-03       Impact factor: 10.122

2.  Impact of acute-phase insulin secretion on glycemic variability in insulin-treated patients with type 2 diabetes.

Authors:  Yiming Si; Yun Shen; Jingyi Lu; Xiaojing Ma; Lei Zhang; Yifei Mo; Wei Lu; Wei Zhu; Yuqian Bao; Gang Hu; Jian Zhou
Journal:  Endocrine       Date:  2020-01-31       Impact factor: 3.633

3.  CXCR1/2 inhibition enhances pancreatic islet survival after transplantation.

Authors:  Antonio Citro; Elisa Cantarelli; Paola Maffi; Rita Nano; Raffaella Melzi; Alessia Mercalli; Erica Dugnani; Valeria Sordi; Paola Magistretti; Luisa Daffonchio; Pier Adelchi Ruffini; Marcello Allegretti; Antonio Secchi; Ezio Bonifacio; Lorenzo Piemonti
Journal:  J Clin Invest       Date:  2012-09-17       Impact factor: 14.808

Review 4.  Immunologic and metabolic biomarkers of β-cell destruction in the diagnosis of type 1 diabetes.

Authors:  Jasmin Lebastchi; Kevan C Herold
Journal:  Cold Spring Harb Perspect Med       Date:  2012-06       Impact factor: 6.915

5.  Mixed-meal tolerance test versus glucagon stimulation test for the assessment of beta-cell function in therapeutic trials in type 1 diabetes.

Authors:  Carla J Greenbaum; Thomas Mandrup-Poulsen; Paula Friedenberg McGee; Tadej Battelino; Burkhard Haastert; Johnny Ludvigsson; Paolo Pozzilli; John M Lachin; Hubert Kolb
Journal:  Diabetes Care       Date:  2008-07-15       Impact factor: 19.112

6.  Lessons from the mixed-meal tolerance test: use of 90-minute and fasting C-peptide in pediatric diabetes.

Authors:  Rachel E J Besser; Beverley M Shields; Rosaura Casas; Andrew T Hattersley; Johnny Ludvigsson
Journal:  Diabetes Care       Date:  2012-10-30       Impact factor: 19.112
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.